Advertisement

Annals of Surgical Oncology

, Volume 21, Issue 1, pp 277–283 | Cite as

Lymph Node Ratio of the Central Compartment is a Significant Predictor for Locoregional Recurrence After Prophylactic Central Neck Dissection in Patients with Thyroid Papillary Carcinoma

  • In Sun Ryu
  • Chan Il Song
  • Seung-Ho Choi
  • Jong-Lyel Roh
  • Soon Yuhl Nam
  • Sang Yoon Kim
Endocrine Tumors

Abstract

Background

Lymph node ratio (LNR) is an important prognosis factor in many solid cancers, but there have been few reports of LNR in papillary thyroid carcinoma (PTC). This study investigated LNR of the central compartment to determine whether LNR has clinical significance as a prognostic predictor for recurrence after prophylactic central neck dissection (pCND) in patients with PTC.

Methods

The study includes 295 consecutive patients who underwent total thyroidectomy with bilateral pCND, which was pathologically diagnosed as N1a PTC. LNR was calculated as the ratio of positive LN to total LN removed.

Results

LNR of 0.65 was significantly meaningful for recurrence when three or more LNs were collected (P < 0.001). The 10-year estimated recurrence-free survival rates were 98.6 % for patients with LNR ≤0.65 and 75.4 % for patients with LNR >0.65 (P < 0.001). Univariate analysis revealed that increasing tumor size and LNR >0.65 were significantly associated with recurrence (P < 0.05 each). No significant association with recurrence was found for age ≥45 years, male gender, microscopic extrathyroidal extension, coexistent chronic lymphocytic thyroiditis, T classification, multicentricity, number of positive LN, and extranodal extension (P > 0.05 each). The only independent variable for recurrence identified by multivariate analysis was LNR >0.65 (P < 0.001).

Conclusions

LNR may be a useful predictor to stratify the likelihood of recurrence after pCND in patients with pathologic N1a PTC.

Keywords

Papillary Thyroid Carcinoma Positive Lymph Node Locoregional Recurrence Lymph Node Ratio Cervical Lymph Node Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

This study was supported by grants from the Bio and Medical Technology Department Program of the National Research Foundation funded by the Korean Government (MEST; 2012028788) and the Intramural Research Program (Theragnosis) of KIST.

Disclosure

The authors declare no conflict of interest.

Supplementary material

10434_2013_3258_MOESM1_ESM.docx (16 kb)
Supplementary material 1 (DOCX 16 kb)

References

  1. 1.
    Lundgren CI, Hall P, Dickman PW, et al. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control study. Cancer. 2006;106:524–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg. 2007;31:2085–91.PubMedCrossRefGoogle Scholar
  3. 3.
    Kim TY, Hong SJ, Kim JM, et al. Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer. 2008;8:296.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Lee YS, Lim YS, Lee JC, et al. Clinical implication of the number of central lymph node metastasis in papillary thyroid carcinoma: preliminary report. World J Surg. 2010;34:2558–63.PubMedCrossRefGoogle Scholar
  5. 5.
    Lin JD, Chao TC, Hsueh C, et al. High recurrent rate of multicentric papillary thyroid carcinoma. Ann Surg Oncol. 2009;16:2609–16.PubMedCrossRefGoogle Scholar
  6. 6.
    Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg. 2001;88:1241–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Kupferman ME, Patterson M, Mandel SJ, et al. Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:857–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Caron NR, Tan YY, Ogilvie JB, et al. Selective modified radical neck dissection for papillary thyroid cancer—is level I, II and V dissection always necessary? World J Surg. 2006;30:833–40.PubMedCrossRefGoogle Scholar
  9. 9.
    Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104:954–62.PubMedGoogle Scholar
  10. 10.
    Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer. 1970;26:1053–60.PubMedCrossRefGoogle Scholar
  11. 11.
    Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim SY, Choi SJ, Kim TY, et al. Is routine central neck dissection necessary for the treatment of papillary thyroid microcarcinoma? Clin Exp Otorhinolaryngol. 2008;1:41–5.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Ito Y, Miyauchi A, Jikuzono T, et al. Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg. 2007;31:838–48.PubMedCrossRefGoogle Scholar
  14. 14.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A; American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  15. 15.
    Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008;15:165–74.PubMedCrossRefGoogle Scholar
  16. 16.
    Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol. 2007;62:95–101.CrossRefGoogle Scholar
  17. 17.
    Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol. 2010;17:2847–55.PubMedCrossRefGoogle Scholar
  18. 18.
    Stulak JM, Grant CS, Farley DR, et al. Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer. Arch Surg. 2006;141:489–94.PubMedCrossRefGoogle Scholar
  19. 19.
    Hwang HS, Orloff LA. Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 2011;121:487–91.PubMedCrossRefGoogle Scholar
  20. 20.
    Moley JF, Lairmore TC, Doherty GM, et al. Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery. 1999;126:673–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Carty SE, Cooper DS, Doherty GM, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19:1153–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003;169:943–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Kamat AM, Kassouf W, Agarwal PK, et al. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008;26:121–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Lyman Ott R, Micheal T. An introduction to statistical methods and data analysis. 3rd ed. Boston: PWS-KENT; 1988.Google Scholar
  25. 25.
    Yuce I, Cagli S, Bayram A, et al. Regional metastatic pattern of papillary thyroid carcinoma. Eur Arch Otorhinolaryngol. 2010;267:437–41.PubMedCrossRefGoogle Scholar
  26. 26.
    Baek SK, Jung KY, Kang SM, et al. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2010;20:147–52.PubMedCrossRefGoogle Scholar
  27. 27.
    Beasley NJ, Lee J, Eski S, et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 2002;128:825–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.PubMedCrossRefGoogle Scholar
  29. 29.
    de Meer SG, Dauwan M, de Keizer B, et al. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer. World J Surg. 2012;36:1262–7.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2013

Authors and Affiliations

  • In Sun Ryu
    • 1
  • Chan Il Song
    • 1
  • Seung-Ho Choi
    • 1
  • Jong-Lyel Roh
    • 1
  • Soon Yuhl Nam
    • 1
  • Sang Yoon Kim
    • 1
    • 2
  1. 1.Department of Otolaryngology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulKorea
  2. 2.Biomedical Research InstituteKorea Institute of Science and TechnologySeoulKorea

Personalised recommendations